About My Health Careers Internship MedBlogs Contact us

Arthritis Sufferers In For More Discomfort

by Ann Samuel on August 2, 2007 at 2:12 PM
Font : A-A+

Arthritis Sufferers In For More Discomfort

According to the National Institute for Health and Clinical Excellence (Nice) arthritis drug abatacept (Orencia) should not be used by the NHS for people with severe arthritis. Campaigners are protesting the decision saying that thousands suffering from an "aggressive" form of arthritis" will denied an ease from their condition.

Around 400,000 people in the UK have rheumatoid arthritis, of which 10 percent (40,000) have a severe form of the disease. They can be offered a class of drugs called anti-TNFs, but around 30 percent of people will not derive any benefit from those.


The National Rheumatoid Arthritis Society (NRAS) says its figures show that people who would fail on anti-TNFs - around 12,000 people - could benefit from a drug such as abatacept. The drug's manufacturer, Bristol-Myers Squibb, have submitted evidence showing that around 3,585 patients in the UK would be eligible for treatment with the drug.

Says Ailsa Bosworth, chief executive of NRAS: "This is extremely bad news for people living with severe rheumatoid arthritis in the UK and a potential step backwards in the management of the condition if this decision is not reversed.

"Denying patients the option of abatacept leaves some of them with the unacceptable choices of being put back on to treatments they have already failed on, palliative care, or taking large doses of steroids which have extremely unacceptable side-effects such as osteoporosis when given over the long term. "We are talking about a relatively small number of patients who have a very aggressive and severe form of rheumatoid arthritis. They will have failed all other treatment options before they are recommended for abatacept", she adds.

Bosworth opines that only people who benefited from the drug would stay on it. "The guidance recommends denying our most severely ill rheumatoid arthritis sufferers one less vital step in their treatment pathway," she adds. "We simply cannot accept that individuals should be denied the chance of at least regaining some quality of life and condemning them to a life of pain and disability, which could be equally as expensive to the NHS."

The draft Nice guidance is now open to consultation, with final guidance expected at the end of the year. A Nice spokeswoman said its independent advisory committee had reviewed the evidence on the clinical and cost-effectiveness of abatacept and taken into account views from patients and other groups.

Source: Medindia

News A-Z
News Category
What's New on Medindia
Cochlear Implants may Consequently Drive Hearing Loss
E-cigarettes Use Linked to Erectile Dysfunction
Memory Loss - Can it be Recovered?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Osteoarthritis Oligoarthritis Spondylolisthesis Knee Replacement Reactive Arthritis Arthritis Septic Arthritis Physiotherapy for Arthritis Adult-Onset Stillīs Disease COX - 2 Inhibitors 

Recommended Reading
Anti-malarial Drug may Help Reduce Risk of Diabetes in Rheumatoid Arthritis Patients
Preliminary research has suggested that use of the anti-malarial drug hydroxychloroquine may help .....
Most parents when told that their child has arthritis find it hard to believe it, as arthritis is .....
Roche’s Arthritis Drug Successful in III Stage Trail
Roche Holding AG says that arthritis drug Actemra has proved successful in a phase III clinical ......
Adult-Onset Stillīs Disease
Adult-Onset Still’s Disease is a rare, inflammatory form of arthritis characterized by fever, pink r...
COX - 2 Inhibitors
What are COX–2 Inhibitors? Why are they safer compared to NSAIDs and which conditions are best trea...
Knee Replacement
Make sprinting a possibility! Relieve chronic arthritic pain by having a knee replacement done at ...
Osteoarthritis is one of the commonest joint disorder and occurs as we age due to wear and tear of a...
Physiotherapy for Arthritis
Physiotherapy enables patients with debilitating disease to regain loss of function in their muscles...
Reactive Arthritis
Reactive arthritis is an autoimmune condition. Ankylosing spondylitis, psoriatic arthritis are disor...
Septic Arthritis
Septic Arthritis or Infectious Arthritis is infection of a joint due to bacteria or other organisms....
Spondylolisthesis is a condition of the lower spine in which one of the bones of the vertebral colum...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use